グローバル症候群検査市場規模、主要企業シェア、ランキング分析レポート【2026年版】
Syndromic Testing - Global Top Players Market Share and Ranking 2026
- レポートID：188788
- 発表時期：2026-02-06
- レポート形式：PDF
- 産業カテゴリー：医療機器と消耗材
- レポート言語：英語、日本語
- ページ数：104
- 発行会社（調査会社）：YHResearch
言語とエディションの価格
- 英語版
- 日本語版
- 英語と日本語版
個人版詳細
マルチユーザー版詳細
企業版詳細
- 英語版
- 日本語版
- 英語と日本語版
価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=158.00円。
※米ドル表示価格+10％消費税。
※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。
レポートの概要
本報告書は、世界の症候群検査市場について包括的な分析を行い、市場全体の動向を明らかにすることを目的としています。総販売数量、売上高、価格動向に加え、主要企業の市場シェアおよび順位を整理し、市場構造を多角的に把握します。さらに、地域・国別、製品タイプ別、用途分野別などの観点から症候群検査市場を分析し、需要構造と成長特性を明確化します。
症候群検査市場の規模、推定値および予測は、2025年を基準年とし、2021年から2032年までの期間における販売数量および売上高に基づいて提示しています。定量分析と定性分析を組み合わせることで、ビジネスおよび成長戦略を検討し、市場競争環境を評価し、企業の市場ポジションを把握した上で、症候群検査に関する的確な意思決定を行うための実践的なインサイトを提供します。
主要症候群検査市場の統計
2025年世界市場規模：3207百万米ドル
2026年世界市場規模：3429百万米ドル
2032年予測市場規模：5200百万米ドル
2026–2032年予測期間CAGR：7.2%
本レポートは症候群検査市場の中長期的な成長動向を定量分析および定性分析の両面から体系的に整理しています。
【市場セグメンテーション】
主要企業・競争環境
症候群検査市場の主要企業には以下が含まれます：
Thermo Fisher Scientific Inc.
Qiagen
Abbott Diagnostics
Vela Diagnostics
Veramarx
Visby Medical
XCR Diagnostics
Beckman Coulter Diagnostics
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc
Bosch Healthcare Solutions GmbH
Genetic Signatures
GenMark Dx (Roche)
Hologic
Roche Molecular Diagnostics
製品別
Respiratory Infections
Sexually Transmitted Infections (STIs)
Gastrointestinal Infections
Central Nervous System Infections
Others
アプリケーション別
Outbreak Response
Emergency Departments
Travel Medicine
Military Medicine
Public Health Surveillance
レポート対象地域
北米：アメリカ、カナダ、その他
アジア太平洋：中国、日本、韓国、東南アジア、インド、オーストラリア、その他
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、オランダ、北欧諸国、その他
ラテンアメリカ：メキシコ、ブラジル、その他
中東・アフリカ：トルコ、サウジアラビア、UAE、その他
レポート構成（章別概要）
第1章｜市場概要と成長展望
症候群検査市場の全体像を整理し、市場規模、売上予測、価格推移を体系的に解説します。同時に成長要因、市場機会、業界課題、リスク要因を分析し、中長期的な市場展望を提示します
第2章｜主要企業の競争分析
症候群検査市場における主要プレイヤー（トップ5社・トップ10社）を対象に、売上高、製造拠点、製品構成、価格戦略、販売量、市場シェアを多面的に分析し、競争構造を明確化します
第3章｜製品カテゴリ別市場動向
製品タイプ別に症候群検査市場を分類し、売上高、市場シェア、販売量、価格動向を分析します。成長性の高い製品分野と市場構造の変化を明らかにします
第4章｜用途別市場動向
用途別に症候群検査市場規模、売上高、市場シェア、販売量、価格推移を整理し、業界別の需要動向と成長ポテンシャルを分析します
第5章｜地域別市場分析
地域別の市場成長率、販売量、売上高を詳細に分析し、症候群検査市場の地理的需要構造を可視化します。各地域の市場規模推移と将来の成長余地を評価します
第6章｜国別市場動向
主要国・地域ごとに、症候群検査市場の販売量、売上高、成長要因、政策・規制環境、競争特性を整理し、国別市場の特徴を明確にします
第7章｜主要企業プロファイル
症候群検査市場を牽引する主要企業について、売上高、販売量、価格動向、粗利益率、製品ポートフォリオ、最新の戦略動向を詳細に解説します
第8章｜バリューチェーンと市場構造分析
業界全体のサプライチェーンを上流から下流まで整理し、コスト構造や流通モデルの動向を分析します
第9章｜調査結果
調査結果を総括し、市場全体のトレンド、今後の成長機会、潜在的リスク、戦略的な洞察を提示します
第10章｜付録（調査手法・データソース）
調査設計、分析手法、使用データソースの詳細を明示し、レポートの信頼性と透明性を担保します
本レポートの要点と洞察
症候群検査市場の全体像と成長見通し
症候群検査市場の規模変化の傾向、成長予測及び需要動向を体系的に整理いたします。2021年から2025年までの実績データに基づき、2032年までの中長期予測を提示し、市場の拡大速度と成長潜在力を明らかにします。同時に、最近の関税調整措置など各国の政策動向を踏まえ、多角的にグローバル経済環境が症候群検査市場に与える影響を分析いたします
市場環境の構成要素とマクロトレンド
症候群検査産業を取り巻く市場環境について、需要構造の変化、政策対応、技術革新の進展といった主要要因を整理します。特に、国際貿易政策や関税政策の変化が企業戦略や価格形成に及ぼす影響、サプライチェーン再編の動きと事業運営への波及効果を明確化し、市場環境の全体像を包括的に提示します
競争構造と主要企業の動向分析
症候群検査市場における主要企業の売上規模、市場シェア、競争ポジションを整理し、競争構造の特徴を分析します。各社の競争戦略、事業拡大の方向性、新製品・新技術の投入動向を通じて、技術革新が市場競争に与える影響と競争環境の変化を解読します
競争環境と事業動向の把握
製品タイプ別、用途別、地域・国別の観点から症候群検査市場のセグメント構造を整理します。各地域の需要構成と成長特性を比較分析し、各細分領域が市場全体の成長に与える貢献度と相互関連性を明確にします
成長要因・課題・リスクの分析
症候群検査市場の成長を支える主要ドライバーを整理するとともに、業界特有の課題や潜在的リスクを分析します。原材料調達、供給システム、事業運営における不確実性を踏まえ、サプライチェーン及び事業レジリエンス強化の方向性についても考察します
将来トレンドと市場展望
症候群検査市場の中長期的な成長トレンドと将来の発展シナリオを提示します。持続的成長を実現するための重要な成功要因を整理し、今後の市場参入企業や既存プレイヤーの戦略的意思決定に参考となる視点を提供いたします
Description
According to YH Research, the global market for Syndromic Testing should grow from US$ 3207 million in 2025 to US$ 5200 million by 2032, with a CAGR of 7.2% for the period of 2026-2032.
Syndromic testing is the process of using one test to simultaneously target multiple pathogens with overlapping signs and symptoms.Syndromic testing is a type of testing used in medical diagnosis that looks for multiple different infectious agents at the same time, often based on the symptoms and signs exhibited by the patient. This type of testing is usually performed when a patient presents with symptoms that are difficult to diagnose or when there is a suspected outbreak of an infectious disease.Syndromic testing is a useful tool in the diagnosis and management of infectious diseases.
The global syndromic testing market refers to the market for diagnostic tests that can rapidly detect and identify the cause of various infectious diseases and syndromes. Syndromic testing involves the simultaneous testing for multiple pathogens or factors that cause similar symptoms or clinical presentations, enabling healthcare providers to quickly diagnose and treat patients.
Here are some key factors influencing the growth of the global syndromic testing market:
Increasing prevalence of infectious diseases: The global burden of infectious diseases, including respiratory infections, gastrointestinal infections, sexually transmitted infections (STIs), and bloodstream infections, is significant. Syndromic testing offers a rapid and comprehensive approach to testing for multiple pathogens associated with these infections. The growing prevalence of infectious diseases is driving the demand for syndromic testing tools and technologies.
Need for rapid diagnosis and treatment: Timely diagnosis is crucial for the effective management and treatment of infectious diseases. Syndromic testing provides rapid results, allowing healthcare providers to quickly identify the cause of a patient’s symptoms and initiate appropriate treatment. Rapid diagnosis can help reduce the spread of infections, improve patient outcomes, and optimize antimicrobial therapy. The need for prompt diagnosis and treatment is fueling the adoption of syndromic testing.
Technological advancements in molecular diagnostics: Syndromic testing relies on molecular diagnostics technologies, such as polymerase chain reaction (PCR), nucleic acid amplification tests (NAATs), and other molecular assays. These technologies have witnessed significant advancements in recent years, with improved sensitivity, specificity, and turnaround times. The development of multiplex assays, which can simultaneously detect multiple pathogens, has further enhanced the efficiency of syndromic testing. Technological advancements are driving the growth of the syndromic testing market.
Increasing focus on antimicrobial stewardship: Antimicrobial stewardship programs aim to optimize the use of antimicrobial drugs to prevent the emergence of antimicrobial resistance. Syndromic testing plays a crucial role in guiding antimicrobial stewardship efforts by providing rapid diagnostic information on the causative pathogens and their susceptibility patterns. By allowing for targeted and appropriate antimicrobial therapy, syndromic testing can help reduce unnecessary antibiotic prescriptions and combat antimicrobial resistance.
COVID-19 pandemic impact: The ongoing COVID-19 pandemic has significantly increased the demand for syndromic testing. Syndromic testing has been crucial in diagnosing and monitoring COVID-19 cases, enabling prompt isolation and treatment. The pandemic has highlighted the importance of syndromic testing in managing infectious diseases and has accelerated the adoption of these testing solutions worldwide.
In summary, the global syndromic testing market is driven by the increasing prevalence of infectious diseases, the need for rapid diagnosis and treatment, technological advancements in molecular diagnostics, the focus on antimicrobial stewardship, and the impact of the COVID-19 pandemic. Syndromic testing offers a comprehensive and efficient approach to diagnosing infectious diseases, enabling timely and targeted interventions. The market is expected to witness significant growth as the demand for rapid and accurate diagnostic solutions continues to rise.The global syndromic testing market refers to the market for diagnostic tests that can rapidly detect and identify the cause of various infectious diseases and syndromes. Syndromic testing involves the simultaneous testing for multiple pathogens or factors that cause similar symptoms or clinical presentations, enabling healthcare providers to quickly diagnose and treat patients.
Here are some key factors influencing the growth of the global syndromic testing market:
Increasing prevalence of infectious diseases: The global burden of infectious diseases, including respiratory infections, gastrointestinal infections, sexually transmitted infections (STIs), and bloodstream infections, is significant. Syndromic testing offers a rapid and comprehensive approach to testing for multiple pathogens associated with these infections. The growing prevalence of infectious diseases is driving the demand for syndromic testing tools and technologies.
Need for rapid diagnosis and treatment: Timely diagnosis is crucial for the effective management and treatment of infectious diseases. Syndromic testing provides rapid results, allowing healthcare providers to quickly identify the cause of a patient’s symptoms and initiate appropriate treatment. Rapid diagnosis can help reduce the spread of infections, improve patient outcomes, and optimize antimicrobial therapy. The need for prompt diagnosis and treatment is fueling the adoption of syndromic testing.
Technological advancements in molecular diagnostics: Syndromic testing relies on molecular diagnostics technologies, such as polymerase chain reaction (PCR), nucleic acid amplification tests (NAATs), and other molecular assays. These technologies have witnessed significant advancements in recent years, with improved sensitivity, specificity, and turnaround times. The development of multiplex assays, which can simultaneously detect multiple pathogens, has further enhanced the efficiency of syndromic testing. Technological advancements are driving the growth of the syndromic testing market.
Increasing focus on antimicrobial stewardship: Antimicrobial stewardship programs aim to optimize the use of antimicrobial drugs to prevent the emergence of antimicrobial resistance. Syndromic testing plays a crucial role in guiding antimicrobial stewardship efforts by providing rapid diagnostic information on the causative pathogens and their susceptibility patterns. By allowing for targeted and appropriate antimicrobial therapy, syndromic testing can help reduce unnecessary antibiotic prescriptions and combat antimicrobial resistance.
COVID-19 pandemic impact: The ongoing COVID-19 pandemic has significantly increased the demand for syndromic testing. Syndromic testing has been crucial in diagnosing and monitoring COVID-19 cases, enabling prompt isolation and treatment. The pandemic has highlighted the importance of syndromic testing in managing infectious diseases and has accelerated the adoption of these testing solutions worldwide.
In summary, the global syndromic testing market is driven by the increasing prevalence of infectious diseases, the need for rapid diagnosis and treatment, technological advancements in molecular diagnostics, the focus on antimicrobial stewardship, and the impact of the COVID-19 pandemic. Syndromic testing offers a comprehensive and efficient approach to diagnosing infectious diseases, enabling timely and targeted interventions. The market is expected to witness significant growth as the demand for rapid and accurate diagnostic solutions continues to rise.
This report studies and analyses global Syndromic Testing status and future trends, to help determine the Syndromic Testing market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Syndromic Testing, and provides market size (US$ million) and Year-over-Year growth, considering 2025 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Syndromic Testing market size, history data 2021-2025, and forecast data 2026 -2032, (US$ million)
(2) Global Syndromic Testing by company, revenue, market share and industry ranking 2021-2026, (US$ million)
(3) Japan Syndromic Testing by company, revenue, market share and industry ranking 2021-2026, (US$ million)
(4) Global Syndromic Testing key consuming regions, consumption value and demand structure
(5) Syndromic Testing industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Thermo Fisher Scientific Inc.
Qiagen
Abbott Diagnostics
Vela Diagnostics
Veramarx
Visby Medical
XCR Diagnostics
Beckman Coulter Diagnostics
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc
Bosch Healthcare Solutions GmbH
Genetic Signatures
GenMark Dx (Roche)
Hologic
Roche Molecular Diagnostics
Market segment by Type, covers
Respiratory Infections
Sexually Transmitted Infections (STIs)
Gastrointestinal Infections
Central Nervous System Infections
Others
Market segment by Application, can be divided into
Outbreak Response
Emergency Departments
Travel Medicine
Military Medicine
Public Health Surveillance
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Syndromic Testing product scope, global consumption value, Japan consumption value, development opportunities, challenges, trends, and policies
Chapter 2: Global Syndromic Testing market share and ranking of major manufacturers, revenue, 2021-2026
Chapter 3: Japan Syndromic Testing market share and ranking of major manufacturers, revenue, 2021-2026
Chapter 4: Syndromic Testing industry chain, upstream, medium-stream, and downstream
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2021-2032
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2021-2032
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2021-2032
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2021-2032
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin
Chapter 10: Conclusions
Table of Contents
1 Market Overview
1.1 Syndromic Testing Definition
1.2 Global Syndromic Testing Market Size and Forecast
1.3 Japan Syndromic Testing Market Size and Forecast
1.4 Share of Japan Syndromic Testing Market with Respect to the Global Market
1.5 Syndromic Testing Market Size: Japan VS Global Growth Rate, 2021-2032
1.6 Syndromic Testing Market Dynamics
1.6.1 Syndromic Testing Market Drivers
1.6.2 Syndromic Testing Market Restraints
1.6.3 Syndromic Testing Industry Trends
1.6.4 Syndromic Testing Industry Policy
2 Global Leading Players and Market Share
2.1 By Revenue of Syndromic Testing, Global Market Share by Company, 2021-2026
2.2 Global Syndromic Testing Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Syndromic Testing Concentration Ratio
2.4 Global Syndromic Testing Mergers & Acquisitions, Expansion Plans
2.5 Global Syndromic Testing Major Companies Product Type
2.6 Head Office and Area Served of Key Players
3 Japan Leading Players, Market Share and Ranking
3.1 By Revenue of Syndromic Testing, Japan Market Share by Company, 2021-2026
3.2 Japan Syndromic Testing Syndromic Testing Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis
4.1 Syndromic Testing Industry Chain
4.2 Syndromic Testing Upstream Analysis
4.2.1 Syndromic Testing Core Raw Materials
4.2.2 Main Manufacturers of Syndromic Testing Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Syndromic Testing Production Mode
4.6 Syndromic Testing Procurement Model
4.7 Syndromic Testing Industry Sales Model and Sales Channels
4.7.1 Syndromic Testing Sales Model
4.7.2 Syndromic Testing Typical Distributors
5 Sights by Type
5.1 Syndromic Testing Classification by Type
5.1.1 Respiratory Infections
5.1.2 Sexually Transmitted Infections (STIs)
5.1.3 Gastrointestinal Infections
5.1.4 Central Nervous System Infections
5.1.5 Others
5.2 by Type, Global Syndromic Testing Consumption Value & CAGR, 2021 VS 2025 VS 2032
5.3 by Type, Global Syndromic Testing Consumption Value, 2021-2032
6 Sights by Application
6.1 Syndromic Testing Segment by Application
6.1.1 Outbreak Response
6.1.2 Emergency Departments
6.1.3 Travel Medicine
6.1.4 Military Medicine
6.1.5 Public Health Surveillance
6.2 by Application, Global Syndromic Testing Consumption Value & CAGR, 2021 VS 2025 VS 2032
6.3 by Application, Global Syndromic Testing Consumption Value, 2021-2032
7 Sales Sights by Region
7.1 By Region, Global Syndromic Testing Consumption Value, 2021 VS 2025 VS 2032
7.2 By Region, Global Syndromic Testing Consumption Value, 2021-2032
7.3 North America
7.3.1 North America Syndromic Testing Market Size & Forecasts, 2021-2032
7.3.2 By Country, North America Syndromic Testing Market Size Market Share
7.4 Europe
7.4.1 Europe Syndromic Testing Market Size & Forecasts, 2021-2032
7.4.2 By Country, Europe Syndromic Testing Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Syndromic Testing Market Size & Forecasts, 2021-2032
7.5.2 By Country/Region, Asia Pacific Syndromic Testing Market Size Market Share
7.6 South America
7.6.1 South AmericaSyndromic Testing Market Size & Forecasts, 2021-2032
7.6.2 By Country, South America Syndromic Testing Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level
8.1 By Country, Global Syndromic Testing Market Size & CAGR, 2021 VS 2025 VS 2032
8.2 By Country, Global Syndromic Testing Consumption Value, 2021-2032
8.3 United States
8.3.1 United States Syndromic Testing Market Size, 2021-2032
8.3.2 by Type, United States Syndromic Testing Consumption Value Market Share, 2025 VS 2032
8.3.3 by Application, United States Syndromic Testing Consumption Value Market Share, 2025 VS 2032
8.4 Europe
8.4.1 Europe Syndromic Testing Market Size, 2021-2032
8.4.2 by Type, Europe Syndromic Testing Consumption Value Market Share, 2025 VS 2032
8.4.3 by Application, Europe Syndromic Testing Consumption Value Market Share, 2025 VS 2032
8.5 China
8.5.1 China Syndromic Testing Market Size, 2021-2032
8.5.2 by Type, China Syndromic Testing Consumption Value Market Share, 2025 VS 2032
8.5.3 by Application, China Syndromic Testing Consumption Value Market Share, 2025 VS 2032
8.6 Japan
8.6.1 Japan Syndromic Testing Market Size, 2021-2032
8.6.2 by Type, Japan Syndromic Testing Consumption Value Market Share, 2025 VS 2032
8.6.3 by Application, Japan Syndromic Testing Consumption Value Market Share, 2025 VS 2032
8.7 South Korea
8.7.1 South Korea Syndromic Testing Market Size, 2021-2032
8.7.2 by Type, South Korea Syndromic Testing Consumption Value Market Share, 2025 VS 2032
8.7.3 by Application, South Korea Syndromic Testing Consumption Value Market Share, 2025 VS 2032
8.8 Southeast Asia
8.8.1 Southeast Asia Syndromic Testing Market Size, 2021-2032
8.8.2 by Type, Southeast Asia Syndromic Testing Consumption Value Market Share, 2025 VS 2032
8.8.3 by Application, Southeast Asia Syndromic Testing Consumption Value Market Share, 2025 VS 2032
8.9 India
8.9.1 India Syndromic Testing Market Size, 2021-2032
8.9.2 by Type, India Syndromic Testing Consumption Value Market Share, 2025 VS 2032
8.9.3 by Application, India Syndromic Testing Consumption Value Market Share, 2025 VS 2032
8.10 Middle East & Africa
8.10.1 Middle East & Africa Syndromic Testing Market Size, 2021-2032
8.10.2 by Type, Middle East & Africa Syndromic Testing Consumption Value Market Share, 2025 VS 2032
8.10.3 by Application, Middle East & Africa Syndromic Testing Consumption Value Market Share, 2025 VS 2032
9 Company Profile
9.1 Thermo Fisher Scientific Inc.
9.1.1 Thermo Fisher Scientific Inc. Company Information, Head Office, Market Area, and Industry Position
9.1.2 Thermo Fisher Scientific Inc. Company Profile and Main Business
9.1.3 Thermo Fisher Scientific Inc. Syndromic Testing Models, Specifications, and Application
9.1.4 Thermo Fisher Scientific Inc. Syndromic Testing Revenue and Gross Margin, 2021-2026
9.1.5 Thermo Fisher Scientific Inc. Recent Developments
9.2 Qiagen
9.2.1 Qiagen Company Information, Head Office, Market Area, and Industry Position
9.2.2 Qiagen Company Profile and Main Business
9.2.3 Qiagen Syndromic Testing Models, Specifications, and Application
9.2.4 Qiagen Syndromic Testing Revenue and Gross Margin, 2021-2026
9.2.5 Qiagen Recent Developments
9.3 Abbott Diagnostics
9.3.1 Abbott Diagnostics Company Information, Head Office, Market Area, and Industry Position
9.3.2 Abbott Diagnostics Company Profile and Main Business
9.3.3 Abbott Diagnostics Syndromic Testing Models, Specifications, and Application
9.3.4 Abbott Diagnostics Syndromic Testing Revenue and Gross Margin, 2021-2026
9.3.5 Abbott Diagnostics Recent Developments
9.4 Vela Diagnostics
9.4.1 Vela Diagnostics Company Information, Head Office, Market Area, and Industry Position
9.4.2 Vela Diagnostics Company Profile and Main Business
9.4.3 Vela Diagnostics Syndromic Testing Models, Specifications, and Application
9.4.4 Vela Diagnostics Syndromic Testing Revenue and Gross Margin, 2021-2026
9.4.5 Vela Diagnostics Recent Developments
9.5 Veramarx
9.5.1 Veramarx Company Information, Head Office, Market Area, and Industry Position
9.5.2 Veramarx Company Profile and Main Business
9.5.3 Veramarx Syndromic Testing Models, Specifications, and Application
9.5.4 Veramarx Syndromic Testing Revenue and Gross Margin, 2021-2026
9.5.5 Veramarx Recent Developments
9.6 Visby Medical
9.6.1 Visby Medical Company Information, Head Office, Market Area, and Industry Position
9.6.2 Visby Medical Company Profile and Main Business
9.6.3 Visby Medical Syndromic Testing Models, Specifications, and Application
9.6.4 Visby Medical Syndromic Testing Revenue and Gross Margin, 2021-2026
9.6.5 Visby Medical Recent Developments
9.7 XCR Diagnostics
9.7.1 XCR Diagnostics Company Information, Head Office, Market Area, and Industry Position
9.7.2 XCR Diagnostics Company Profile and Main Business
9.7.3 XCR Diagnostics Syndromic Testing Models, Specifications, and Application
9.7.4 XCR Diagnostics Syndromic Testing Revenue and Gross Margin, 2021-2026
9.7.5 XCR Diagnostics Recent Developments
9.8 Beckman Coulter Diagnostics
9.8.1 Beckman Coulter Diagnostics Company Information, Head Office, Market Area, and Industry Position
9.8.2 Beckman Coulter Diagnostics Company Profile and Main Business
9.8.3 Beckman Coulter Diagnostics Syndromic Testing Models, Specifications, and Application
9.8.4 Beckman Coulter Diagnostics Syndromic Testing Revenue and Gross Margin, 2021-2026
9.8.5 Beckman Coulter Diagnostics Recent Developments
9.9 Becton, Dickinson and Company
9.9.1 Becton, Dickinson and Company Company Information, Head Office, Market Area, and Industry Position
9.9.2 Becton, Dickinson and Company Company Profile and Main Business
9.9.3 Becton, Dickinson and Company Syndromic Testing Models, Specifications, and Application
9.9.4 Becton, Dickinson and Company Syndromic Testing Revenue and Gross Margin, 2021-2026
9.9.5 Becton, Dickinson and Company Recent Developments
9.10 Bio-Rad Laboratories, Inc
9.10.1 Bio-Rad Laboratories, Inc Company Information, Head Office, Market Area, and Industry Position
9.10.2 Bio-Rad Laboratories, Inc Company Profile and Main Business
9.10.3 Bio-Rad Laboratories, Inc Syndromic Testing Models, Specifications, and Application
9.10.4 Bio-Rad Laboratories, Inc Syndromic Testing Revenue and Gross Margin, 2021-2026
9.10.5 Bio-Rad Laboratories, Inc Recent Developments
9.11 Bosch Healthcare Solutions GmbH
9.11.1 Bosch Healthcare Solutions GmbH Company Information, Head Office, Market Area, and Industry Position
9.11.2 Bosch Healthcare Solutions GmbH Company Profile and Main Business
9.11.3 Bosch Healthcare Solutions GmbH Syndromic Testing Models, Specifications, and Application
9.11.4 Bosch Healthcare Solutions GmbH Syndromic Testing Revenue and Gross Margin, 2021-2026
9.11.5 Bosch Healthcare Solutions GmbH Recent Developments
9.12 Genetic Signatures
9.12.1 Genetic Signatures Company Information, Head Office, Market Area, and Industry Position
9.12.2 Genetic Signatures Company Profile and Main Business
9.12.3 Genetic Signatures Syndromic Testing Models, Specifications, and Application
9.12.4 Genetic Signatures Syndromic Testing Revenue and Gross Margin, 2021-2026
9.12.5 Genetic Signatures Recent Developments
9.13 GenMark Dx (Roche)
9.13.1 GenMark Dx (Roche) Company Information, Head Office, Market Area, and Industry Position
9.13.2 GenMark Dx (Roche) Company Profile and Main Business
9.13.3 GenMark Dx (Roche) Syndromic Testing Models, Specifications, and Application
9.13.4 GenMark Dx (Roche) Syndromic Testing Revenue and Gross Margin, 2021-2026
9.13.5 GenMark Dx (Roche) Recent Developments
9.14 Hologic
9.14.1 Hologic Company Information, Head Office, Market Area, and Industry Position
9.14.2 Hologic Company Profile and Main Business
9.14.3 Hologic Syndromic Testing Models, Specifications, and Application
9.14.4 Hologic Syndromic Testing Revenue and Gross Margin, 2021-2026
9.14.5 Hologic Recent Developments
9.15 Roche Molecular Diagnostics
9.15.1 Roche Molecular Diagnostics Company Information, Head Office, Market Area, and Industry Position
9.15.2 Roche Molecular Diagnostics Company Profile and Main Business
9.15.3 Roche Molecular Diagnostics Syndromic Testing Models, Specifications, and Application
9.15.4 Roche Molecular Diagnostics Syndromic Testing Revenue and Gross Margin, 2021-2026
9.15.5 Roche Molecular Diagnostics Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Table of Figures
List of Tables Table 1. Syndromic Testing Consumption Value & CAGR: Japan VS Global, 2021-2032, US$ Million Table 2. Syndromic Testing Market Restraints Table 3. Syndromic Testing Market Trends Table 4. Syndromic Testing Industry Policy Table 5. Global Syndromic Testing Revenue by Company, 2021-2026, US$ million, Ranked Based on Revenue in 2025 Table 6. Global Syndromic Testing Revenue Share by Company, 2021-2026, Ranked by Data of 2025 Table 7. Global Syndromic Testing Manufacturers Market Concentration Ratio (CR3 and HHI) Table 8. Global Syndromic Testing Mergers & Acquisitions, Expansion Plans Table 9. Global Syndromic Testing Major Companies Product Type Table 10. Head Office and Area Served of Key Players Table 11. Japan Syndromic Testing Revenue by Company, 2021-2026, US$ million, Ranked Based on Revenue in 2025 Table 12. Japan Syndromic Testing Revenue Market Share by Company, 2021-2026 Table 13. Global Key Players of Syndromic Testing Upstream (Raw Materials) Table 14. Global Syndromic Testing Typical Customers Table 15. Syndromic Testing Typical Distributors Table 16. by Type, Global Syndromic Testing Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million Table 17. by Application, Global Syndromic Testing Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million Table 18. By Region, Global Syndromic Testing Consumption Value, 2021 VS 2025 VS 2032, US$ Million Table 19. By Region, Global Syndromic Testing Consumption Value, 2021-2032, US$ Million Table 20. By Country, Global Syndromic Testing Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million Table 21. By Country, Global Syndromic Testing Consumption Value, 2021-2032, US$ Million Table 22. By Country, Global Syndromic Testing Consumption Value Market Share, 2021-2032 Table 23. Thermo Fisher Scientific Inc. Company Information, Head Office, Market Area, and Industry Position Table 24. Thermo Fisher Scientific Inc. Company Profile and Main Business Table 25. Thermo Fisher Scientific Inc. Syndromic Testing Models, Specifications, and Application Table 26. Thermo Fisher Scientific Inc. Syndromic Testing Revenue and Gross Margin, US$ Million, 2021-2026 Table 27. Thermo Fisher Scientific Inc. Recent Developments Table 28. Qiagen Company Information, Head Office, Market Area, and Industry Position Table 29. Qiagen Company Profile and Main Business Table 30. Qiagen Syndromic Testing Models, Specifications, and Application Table 31. Qiagen Syndromic Testing Revenue and Gross Margin, US$ Million, 2021-2026 Table 32. Qiagen Recent Developments Table 33. Abbott Diagnostics Company Information, Head Office, Market Area, and Industry Position Table 34. Abbott Diagnostics Company Profile and Main Business Table 35. Abbott Diagnostics Syndromic Testing Models, Specifications, and Application Table 36. Abbott Diagnostics Syndromic Testing Revenue and Gross Margin, US$ Million, 2021-2026 Table 37. Abbott Diagnostics Recent Developments Table 38. Vela Diagnostics Company Information, Head Office, Market Area, and Industry Position Table 39. Vela Diagnostics Company Profile and Main Business Table 40. Vela Diagnostics Syndromic Testing Models, Specifications, and Application Table 41. Vela Diagnostics Syndromic Testing Revenue and Gross Margin, US$ Million, 2021-2026 Table 42. Vela Diagnostics Recent Developments Table 43. Veramarx Company Information, Head Office, Market Area, and Industry Position Table 44. Veramarx Company Profile and Main Business Table 45. Veramarx Syndromic Testing Models, Specifications, and Application Table 46. Veramarx Syndromic Testing Revenue and Gross Margin, US$ Million, 2021-2026 Table 47. Veramarx Recent Developments Table 48. Visby Medical Company Information, Head Office, Market Area, and Industry Position Table 49. Visby Medical Company Profile and Main Business Table 50. Visby Medical Syndromic Testing Models, Specifications, and Application Table 51. Visby Medical Syndromic Testing Revenue and Gross Margin, US$ Million, 2021-2026 Table 52. Visby Medical Recent Developments Table 53. XCR Diagnostics Company Information, Head Office, Market Area, and Industry Position Table 54. XCR Diagnostics Company Profile and Main Business Table 55. XCR Diagnostics Syndromic Testing Models, Specifications, and Application Table 56. XCR Diagnostics Syndromic Testing Revenue and Gross Margin, US$ Million, 2021-2026 Table 57. XCR Diagnostics Recent Developments Table 58. Beckman Coulter Diagnostics Company Information, Head Office, Market Area, and Industry Position Table 59. Beckman Coulter Diagnostics Company Profile and Main Business Table 60. Beckman Coulter Diagnostics Syndromic Testing Models, Specifications, and Application Table 61. Beckman Coulter Diagnostics Syndromic Testing Revenue and Gross Margin, US$ Million, 2021-2026 Table 62. Beckman Coulter Diagnostics Recent Developments Table 63. Becton, Dickinson and Company Company Information, Head Office, Market Area, and Industry Position Table 64. Becton, Dickinson and Company Company Profile and Main Business Table 65. Becton, Dickinson and Company Syndromic Testing Models, Specifications, and Application Table 66. Becton, Dickinson and Company Syndromic Testing Revenue and Gross Margin, US$ Million, 2021-2026 Table 67. Becton, Dickinson and Company Recent Developments Table 68. Bio-Rad Laboratories, Inc Company Information, Head Office, Market Area, and Industry Position Table 69. Bio-Rad Laboratories, Inc Company Profile and Main Business Table 70. Bio-Rad Laboratories, Inc Syndromic Testing Models, Specifications, and Application Table 71. Bio-Rad Laboratories, Inc Syndromic Testing Revenue and Gross Margin, US$ Million, 2021-2026 Table 72. Bio-Rad Laboratories, Inc Recent Developments Table 73. Bosch Healthcare Solutions GmbH Company Information, Head Office, Market Area, and Industry Position Table 74. Bosch Healthcare Solutions GmbH Company Profile and Main Business Table 75. Bosch Healthcare Solutions GmbH Syndromic Testing Models, Specifications, and Application Table 76. Bosch Healthcare Solutions GmbH Syndromic Testing Revenue and Gross Margin, US$ Million, 2021-2026 Table 77. Bosch Healthcare Solutions GmbH Recent Developments Table 78. Genetic Signatures Company Information, Head Office, Market Area, and Industry Position Table 79. Genetic Signatures Company Profile and Main Business Table 80. Genetic Signatures Syndromic Testing Models, Specifications, and Application Table 81. Genetic Signatures Syndromic Testing Revenue and Gross Margin, US$ Million, 2021-2026 Table 82. Genetic Signatures Recent Developments Table 83. GenMark Dx (Roche) Company Information, Head Office, Market Area, and Industry Position Table 84. GenMark Dx (Roche) Company Profile and Main Business Table 85. GenMark Dx (Roche) Syndromic Testing Models, Specifications, and Application Table 86. GenMark Dx (Roche) Syndromic Testing Revenue and Gross Margin, US$ Million, 2021-2026 Table 87. GenMark Dx (Roche) Recent Developments Table 88. Hologic Company Information, Head Office, Market Area, and Industry Position Table 89. Hologic Company Profile and Main Business Table 90. Hologic Syndromic Testing Models, Specifications, and Application Table 91. Hologic Syndromic Testing Revenue and Gross Margin, US$ Million, 2021-2026 Table 92. Hologic Recent Developments Table 93. Roche Molecular Diagnostics Company Information, Head Office, Market Area, and Industry Position Table 94. Roche Molecular Diagnostics Company Profile and Main Business Table 95. Roche Molecular Diagnostics Syndromic Testing Models, Specifications, and Application Table 96. Roche Molecular Diagnostics Syndromic Testing Revenue and Gross Margin, US$ Million, 2021-2026 Table 97. Roche Molecular Diagnostics Recent Developments List of Figures Figure 1. Syndromic Testing Picture Figure 2. Global Syndromic Testing Consumption Value, (US$ million) & (2021-2032) Figure 3. Japan Syndromic Testing Consumption Value, (US$ million) & (2021-2032) Figure 4. By Consumption Value, Japan Syndromic Testing Market Share of Global, 2021-2032 Figure 5. Global Syndromic Testing Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2025 Figure 6. Japan Syndromic Testing Key Participants, Market Share, 2025 Figure 7. Syndromic Testing Industry Chain Figure 8. Syndromic Testing Procurement Model Figure 9. Syndromic Testing Sales Model Figure 10. Syndromic Testing Sales Channels, Direct Sales, and Distribution Figure 11. Respiratory Infections Figure 12. Sexually Transmitted Infections (STIs) Figure 13. Gastrointestinal Infections Figure 14. Central Nervous System Infections Figure 15. Others Figure 16. by Type, Global Syndromic Testing Consumption Value, 2021-2032, US$ Million Figure 17. by Type, Global Syndromic Testing Consumption Value Market Share, 2021-2032 Figure 18. Outbreak Response Figure 19. Emergency Departments Figure 20. Travel Medicine Figure 21. Military Medicine Figure 22. Public Health Surveillance Figure 23. by Application, Global Syndromic Testing Consumption Value, 2021-2032, US$ Million Figure 24. by Application, Global Syndromic Testing Revenue Market Share, 2021-2032 Figure 25. By Region, Global Syndromic Testing Consumption Value Market Share, 2021-2032 Figure 26. North America Syndromic Testing Consumption Value & Forecasts, 2021-2032, US$ Million Figure 27. By Country, North America Syndromic Testing Consumption Value Market Share, 2025 Figure 28. Europe Syndromic Testing Consumption Value & Forecasts, 2021-2032, US$ Million Figure 29. By Country, Europe Syndromic Testing Consumption Value Market Share, 2025 Figure 30. Asia Pacific Syndromic Testing Consumption Value & Forecasts, 2021-2032, US$ Million Figure 31. By Country/Region, Asia Pacific Syndromic Testing Consumption Value Market Share, 2025 Figure 32. South America Syndromic Testing Consumption Value & Forecasts, 2021-2032, US$ Million Figure 33. By Country, South America Syndromic Testing Consumption Value Market Share, 2025 Figure 34. Middle East & Africa Syndromic Testing Consumption Value & Forecasts, 2021-2032, US$ Million Figure 35. United States Syndromic Testing Consumption Value, 2021-2032, US$ Million Figure 36. by Type, United States Syndromic Testing Consumption Value Market Share, 2025 VS 2032 Figure 37. by Application, United States Syndromic Testing Consumption Value Market Share, 2025 VS 2032 Figure 38. Europe Syndromic Testing Consumption Value, 2021-2032, US$ Million Figure 39. by Type, Europe Syndromic Testing Consumption Value Market Share, 2025 VS 2032 Figure 40. by Application, Europe Syndromic Testing Consumption Value Market Share, 2025 VS 2032 Figure 41. China Syndromic Testing Consumption Value, 2021-2032, US$ Million Figure 42. by Type, China Syndromic Testing Consumption Value Market Share, 2025 VS 2032 Figure 43. by Application, China Syndromic Testing Consumption Value Market Share, 2025 VS 2032 Figure 44. Japan Syndromic Testing Consumption Value, 2021-2032, US$ Million Figure 45. by Type, Japan Syndromic Testing Consumption Value Market Share, 2025 VS 2032 Figure 46. by Application, Japan Syndromic Testing Consumption Value Market Share, 2025 VS 2032 Figure 47. South Korea Syndromic Testing Consumption Value, 2021-2032, US$ Million Figure 48. by Type, South Korea Syndromic Testing Consumption Value Market Share, 2025 VS 2032 Figure 49. by Application, South Korea Syndromic Testing Consumption Value Market Share, 2025 VS 2032 Figure 50. Southeast Asia Syndromic Testing Consumption Value, 2021-2032, US$ Million Figure 51. by Type, Southeast Asia Syndromic Testing Consumption Value Market Share, 2025 VS 2032 Figure 52. by Application, Southeast Asia Syndromic Testing Consumption Value Market Share, 2025 VS 2032 Figure 53. India Syndromic Testing Consumption Value, 2021-2032, US$ Million Figure 54. by Type, India Syndromic Testing Consumption Value Market Share, 2025 VS 2032 Figure 55. by Application, India Syndromic Testing Consumption Value Market Share, 2025 VS 2032 Figure 56. Middle East & Africa Syndromic Testing Consumption Value, 2021-2032, US$ Million Figure 57. by Type, Middle East & Africa Syndromic Testing Consumption Value Market Share, 2025 VS 2032 Figure 58. by Application, Middle East & Africa Syndromic Testing Consumption Value Market Share, 2025 VS 2032 Figure 59. Research Methodology Figure 60. Breakdown of Primary Interviews Figure 61. Bottom-up Approaches Figure 62. Top-down Approaches
お見積>
サンプルお申込み>
今すぐ購入>
PDFダウンロード>
当社から購入のメリット
多言語（英語、日本語）のサンプル提供
プロフェッショナルな日本語翻訳を提供
請求書、クレジットカードでのお支払いが可能です
必要なチャプターやカスタマイズされたレポートの注文が可能
購入後、アナリストに直接連絡することができます
購入方法
必要な言語とバージョンのレポート選択
レポート要件と見積もり依頼
電子メールによる注文
レポートの入手（英語版は2～4営業日、日本語版は8～10営業日）
クレジットカード決済、オフライン振込に対応（後払い可）
クライアント様（例）
050-5840-2692 日本
0081-50-5840-2692 グローバル
info@globalreports.jp